Olivier Negre

Olivier earned an engineering degree in biotechnology from ENSTBB and a PhD in cell and molecular biology from Paris Diderot University. He has been working for more than 20 years in the field of biotherapies including the production of recombinant proteins with BioProtein Technologies and gene therapy programs at bluebird bio both in France and in the USA. Olivier is a board member of the French Society of Gene and Cell Therapy, co-president of the think tank Gene & Cell Therapy Institute, co-founder of Biotherapy Partners and currently VP, head of R&D at Smart Immune.